ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -2.3% | 27,904 | +39.4% | 0.00% | – |
| Q4 2021 | $43,000 | -54.7% | 20,015 | -25.1% | 0.00% | – |
| Q3 2021 | $95,000 | -45.4% | 26,708 | -11.7% | 0.00% | – |
| Q2 2021 | $174,000 | +10.8% | 30,231 | 0.0% | 0.00% | – |
| Q1 2021 | $157,000 | +118.1% | 30,231 | -0.1% | 0.00% | – |
| Q4 2020 | $72,000 | +157.1% | 30,262 | +49.5% | 0.00% | – |
| Q3 2020 | $28,000 | -3.4% | 20,246 | +31.6% | 0.00% | – |
| Q2 2020 | $29,000 | – | 15,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
| Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
| Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
| Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
| Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
| AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
| WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |